Global Oncolytic Virus Drug Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Oncolytic Virus Drug Treatment market size was valued at USD 6 million in 2023 and is forecast to a readjusted size of USD 28 million by 2030 with a CAGR of 23.8% during review period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Oncolytic Virus Drug Treatment industry chain, the market status of Melanoma (Phase 1, Phase 2), Prostate Cancer (Phase 1, Phase 2), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Oncolytic Virus Drug Treatment.

Regionally, the report analyzes the Oncolytic Virus Drug Treatment markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Oncolytic Virus Drug Treatment market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Oncolytic Virus Drug Treatment market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Oncolytic Virus Drug Treatment industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Phase 1, Phase 2).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Oncolytic Virus Drug Treatment market.

Regional Analysis: The report involves examining the Oncolytic Virus Drug Treatment market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Oncolytic Virus Drug Treatment market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Oncolytic Virus Drug Treatment:
Company Analysis: Report covers individual Oncolytic Virus Drug Treatment players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Oncolytic Virus Drug Treatment This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Melanoma, Prostate Cancer).

Technology Analysis: Report covers specific technologies relevant to Oncolytic Virus Drug Treatment. It assesses the current state, advancements, and potential future developments in Oncolytic Virus Drug Treatment areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Oncolytic Virus Drug Treatment market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Oncolytic Virus Drug Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Phase 1
    Phase 2
    Others

Market segment by Application
    Melanoma
    Prostate Cancer
    Breast Cancer
    Ovarian Cancer
    Others

Market segment by players, this report covers
    Amgen
    Oncolytics Biotech
    Viralytics
    Transgene SA
    Oncolys BioPharma
    Targovax
    PsiOxus Therapeutics
    SillaJen Biotherapeutics
    Sorrento Therapeutics
    Lokon Pharma
    Genelux Corporation
    Vyriad
    TILT Biotherapeutics
    Cold Genesys

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oncolytic Virus Drug Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oncolytic Virus Drug Treatment, with revenue, gross margin and global market share of Oncolytic Virus Drug Treatment from 2019 to 2024.
Chapter 3, the Oncolytic Virus Drug Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Oncolytic Virus Drug Treatment market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncolytic Virus Drug Treatment.
Chapter 13, to describe Oncolytic Virus Drug Treatment research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Oncolytic Virus Drug Treatment
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Oncolytic Virus Drug Treatment by Type
        1.3.1 Overview: Global Oncolytic Virus Drug Treatment Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Oncolytic Virus Drug Treatment Consumption Value Market Share by Type in 2023
        1.3.3 Phase 1
        1.3.4 Phase 2
        1.3.5 Others
    1.4 Global Oncolytic Virus Drug Treatment Market by Application
        1.4.1 Overview: Global Oncolytic Virus Drug Treatment Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Melanoma
        1.4.3 Prostate Cancer
        1.4.4 Breast Cancer
        1.4.5 Ovarian Cancer
        1.4.6 Others
    1.5 Global Oncolytic Virus Drug Treatment Market Size & Forecast
    1.6 Global Oncolytic Virus Drug Treatment Market Size and Forecast by Region
        1.6.1 Global Oncolytic Virus Drug Treatment Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Oncolytic Virus Drug Treatment Market Size by Region, (2019-2030)
        1.6.3 North America Oncolytic Virus Drug Treatment Market Size and Prospect (2019-2030)
        1.6.4 Europe Oncolytic Virus Drug Treatment Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Oncolytic Virus Drug Treatment Market Size and Prospect (2019-2030)
        1.6.6 South America Oncolytic Virus Drug Treatment Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Oncolytic Virus Drug Treatment Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Amgen
        2.1.1 Amgen Details
        2.1.2 Amgen Major Business
        2.1.3 Amgen Oncolytic Virus Drug Treatment Product and Solutions
        2.1.4 Amgen Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Amgen Recent Developments and Future Plans
    2.2 Oncolytics Biotech
        2.2.1 Oncolytics Biotech Details
        2.2.2 Oncolytics Biotech Major Business
        2.2.3 Oncolytics Biotech Oncolytic Virus Drug Treatment Product and Solutions
        2.2.4 Oncolytics Biotech Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Oncolytics Biotech Recent Developments and Future Plans
    2.3 Viralytics
        2.3.1 Viralytics Details
        2.3.2 Viralytics Major Business
        2.3.3 Viralytics Oncolytic Virus Drug Treatment Product and Solutions
        2.3.4 Viralytics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Viralytics Recent Developments and Future Plans
    2.4 Transgene SA
        2.4.1 Transgene SA Details
        2.4.2 Transgene SA Major Business
        2.4.3 Transgene SA Oncolytic Virus Drug Treatment Product and Solutions
        2.4.4 Transgene SA Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Transgene SA Recent Developments and Future Plans
    2.5 Oncolys BioPharma
        2.5.1 Oncolys BioPharma Details
        2.5.2 Oncolys BioPharma Major Business
        2.5.3 Oncolys BioPharma Oncolytic Virus Drug Treatment Product and Solutions
        2.5.4 Oncolys BioPharma Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Oncolys BioPharma Recent Developments and Future Plans
    2.6 Targovax
        2.6.1 Targovax Details
        2.6.2 Targovax Major Business
        2.6.3 Targovax Oncolytic Virus Drug Treatment Product and Solutions
        2.6.4 Targovax Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Targovax Recent Developments and Future Plans
    2.7 PsiOxus Therapeutics
        2.7.1 PsiOxus Therapeutics Details
        2.7.2 PsiOxus Therapeutics Major Business
        2.7.3 PsiOxus Therapeutics Oncolytic Virus Drug Treatment Product and Solutions
        2.7.4 PsiOxus Therapeutics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 PsiOxus Therapeutics Recent Developments and Future Plans
    2.8 SillaJen Biotherapeutics
        2.8.1 SillaJen Biotherapeutics Details
        2.8.2 SillaJen Biotherapeutics Major Business
        2.8.3 SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Product and Solutions
        2.8.4 SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 SillaJen Biotherapeutics Recent Developments and Future Plans
    2.9 Sorrento Therapeutics
        2.9.1 Sorrento Therapeutics Details
        2.9.2 Sorrento Therapeutics Major Business
        2.9.3 Sorrento Therapeutics Oncolytic Virus Drug Treatment Product and Solutions
        2.9.4 Sorrento Therapeutics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Sorrento Therapeutics Recent Developments and Future Plans
    2.10 Lokon Pharma
        2.10.1 Lokon Pharma Details
        2.10.2 Lokon Pharma Major Business
        2.10.3 Lokon Pharma Oncolytic Virus Drug Treatment Product and Solutions
        2.10.4 Lokon Pharma Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Lokon Pharma Recent Developments and Future Plans
    2.11 Genelux Corporation
        2.11.1 Genelux Corporation Details
        2.11.2 Genelux Corporation Major Business
        2.11.3 Genelux Corporation Oncolytic Virus Drug Treatment Product and Solutions
        2.11.4 Genelux Corporation Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Genelux Corporation Recent Developments and Future Plans
    2.12 Vyriad
        2.12.1 Vyriad Details
        2.12.2 Vyriad Major Business
        2.12.3 Vyriad Oncolytic Virus Drug Treatment Product and Solutions
        2.12.4 Vyriad Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Vyriad Recent Developments and Future Plans
    2.13 TILT Biotherapeutics
        2.13.1 TILT Biotherapeutics Details
        2.13.2 TILT Biotherapeutics Major Business
        2.13.3 TILT Biotherapeutics Oncolytic Virus Drug Treatment Product and Solutions
        2.13.4 TILT Biotherapeutics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 TILT Biotherapeutics Recent Developments and Future Plans
    2.14 Cold Genesys
        2.14.1 Cold Genesys Details
        2.14.2 Cold Genesys Major Business
        2.14.3 Cold Genesys Oncolytic Virus Drug Treatment Product and Solutions
        2.14.4 Cold Genesys Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 Cold Genesys Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Oncolytic Virus Drug Treatment Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Oncolytic Virus Drug Treatment by Company Revenue
        3.2.2 Top 3 Oncolytic Virus Drug Treatment Players Market Share in 2023
        3.2.3 Top 6 Oncolytic Virus Drug Treatment Players Market Share in 2023
    3.3 Oncolytic Virus Drug Treatment Market: Overall Company Footprint Analysis
        3.3.1 Oncolytic Virus Drug Treatment Market: Region Footprint
        3.3.2 Oncolytic Virus Drug Treatment Market: Company Product Type Footprint
        3.3.3 Oncolytic Virus Drug Treatment Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Oncolytic Virus Drug Treatment Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Oncolytic Virus Drug Treatment Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Oncolytic Virus Drug Treatment Consumption Value Market Share by Application (2019-2024)
    5.2 Global Oncolytic Virus Drug Treatment Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Oncolytic Virus Drug Treatment Consumption Value by Type (2019-2030)
    6.2 North America Oncolytic Virus Drug Treatment Consumption Value by Application (2019-2030)
    6.3 North America Oncolytic Virus Drug Treatment Market Size by Country
        6.3.1 North America Oncolytic Virus Drug Treatment Consumption Value by Country (2019-2030)
        6.3.2 United States Oncolytic Virus Drug Treatment Market Size and Forecast (2019-2030)
        6.3.3 Canada Oncolytic Virus Drug Treatment Market Size and Forecast (2019-2030)
        6.3.4 Mexico Oncolytic Virus Drug Treatment Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Oncolytic Virus Drug Treatment Consumption Value by Type (2019-2030)
    7.2 Europe Oncolytic Virus Drug Treatment Consumption Value by Application (2019-2030)
    7.3 Europe Oncolytic Virus Drug Treatment Market Size by Country
        7.3.1 Europe Oncolytic Virus Drug Treatment Consumption Value by Country (2019-2030)
        7.3.2 Germany Oncolytic Virus Drug Treatment Market Size and Forecast (2019-2030)
        7.3.3 France Oncolytic Virus Drug Treatment Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Oncolytic Virus Drug Treatment Market Size and Forecast (2019-2030)
        7.3.5 Russia Oncolytic Virus Drug Treatment Market Size and Forecast (2019-2030)
        7.3.6 Italy Oncolytic Virus Drug Treatment Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Oncolytic Virus Drug Treatment Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Oncolytic Virus Drug Treatment Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Oncolytic Virus Drug Treatment Market Size by Region
        8.3.1 Asia-Pacific Oncolytic Virus Drug Treatment Consumption Value by Region (2019-2030)
        8.3.2 China Oncolytic Virus Drug Treatment Market Size and Forecast (2019-2030)
        8.3.3 Japan Oncolytic Virus Drug Treatment Market Size and Forecast (2019-2030)
        8.3.4 South Korea Oncolytic Virus Drug Treatment Market Size and Forecast (2019-2030)
        8.3.5 India Oncolytic Virus Drug Treatment Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Oncolytic Virus Drug Treatment Market Size and Forecast (2019-2030)
        8.3.7 Australia Oncolytic Virus Drug Treatment Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Oncolytic Virus Drug Treatment Consumption Value by Type (2019-2030)
    9.2 South America Oncolytic Virus Drug Treatment Consumption Value by Application (2019-2030)
    9.3 South America Oncolytic Virus Drug Treatment Market Size by Country
        9.3.1 South America Oncolytic Virus Drug Treatment Consumption Value by Country (2019-2030)
        9.3.2 Brazil Oncolytic Virus Drug Treatment Market Size and Forecast (2019-2030)
        9.3.3 Argentina Oncolytic Virus Drug Treatment Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Oncolytic Virus Drug Treatment Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Oncolytic Virus Drug Treatment Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Oncolytic Virus Drug Treatment Market Size by Country
        10.3.1 Middle East & Africa Oncolytic Virus Drug Treatment Consumption Value by Country (2019-2030)
        10.3.2 Turkey Oncolytic Virus Drug Treatment Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Oncolytic Virus Drug Treatment Market Size and Forecast (2019-2030)
        10.3.4 UAE Oncolytic Virus Drug Treatment Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Oncolytic Virus Drug Treatment Market Drivers
    11.2 Oncolytic Virus Drug Treatment Market Restraints
    11.3 Oncolytic Virus Drug Treatment Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Oncolytic Virus Drug Treatment Industry Chain
    12.2 Oncolytic Virus Drug Treatment Upstream Analysis
    12.3 Oncolytic Virus Drug Treatment Midstream Analysis
    12.4 Oncolytic Virus Drug Treatment Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Oncolytic Virus Drug Treatment Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Oncolytic Virus Drug Treatment Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Oncolytic Virus Drug Treatment Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Oncolytic Virus Drug Treatment Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Amgen Company Information, Head Office, and Major Competitors
    Table 6. Amgen Major Business
    Table 7. Amgen Oncolytic Virus Drug Treatment Product and Solutions
    Table 8. Amgen Oncolytic Virus Drug Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Amgen Recent Developments and Future Plans
    Table 10. Oncolytics Biotech Company Information, Head Office, and Major Competitors
    Table 11. Oncolytics Biotech Major Business
    Table 12. Oncolytics Biotech Oncolytic Virus Drug Treatment Product and Solutions
    Table 13. Oncolytics Biotech Oncolytic Virus Drug Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Oncolytics Biotech Recent Developments and Future Plans
    Table 15. Viralytics Company Information, Head Office, and Major Competitors
    Table 16. Viralytics Major Business
    Table 17. Viralytics Oncolytic Virus Drug Treatment Product and Solutions
    Table 18. Viralytics Oncolytic Virus Drug Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Viralytics Recent Developments and Future Plans
    Table 20. Transgene SA Company Information, Head Office, and Major Competitors
    Table 21. Transgene SA Major Business
    Table 22. Transgene SA Oncolytic Virus Drug Treatment Product and Solutions
    Table 23. Transgene SA Oncolytic Virus Drug Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Transgene SA Recent Developments and Future Plans
    Table 25. Oncolys BioPharma Company Information, Head Office, and Major Competitors
    Table 26. Oncolys BioPharma Major Business
    Table 27. Oncolys BioPharma Oncolytic Virus Drug Treatment Product and Solutions
    Table 28. Oncolys BioPharma Oncolytic Virus Drug Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Oncolys BioPharma Recent Developments and Future Plans
    Table 30. Targovax Company Information, Head Office, and Major Competitors
    Table 31. Targovax Major Business
    Table 32. Targovax Oncolytic Virus Drug Treatment Product and Solutions
    Table 33. Targovax Oncolytic Virus Drug Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Targovax Recent Developments and Future Plans
    Table 35. PsiOxus Therapeutics Company Information, Head Office, and Major Competitors
    Table 36. PsiOxus Therapeutics Major Business
    Table 37. PsiOxus Therapeutics Oncolytic Virus Drug Treatment Product and Solutions
    Table 38. PsiOxus Therapeutics Oncolytic Virus Drug Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. PsiOxus Therapeutics Recent Developments and Future Plans
    Table 40. SillaJen Biotherapeutics Company Information, Head Office, and Major Competitors
    Table 41. SillaJen Biotherapeutics Major Business
    Table 42. SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Product and Solutions
    Table 43. SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. SillaJen Biotherapeutics Recent Developments and Future Plans
    Table 45. Sorrento Therapeutics Company Information, Head Office, and Major Competitors
    Table 46. Sorrento Therapeutics Major Business
    Table 47. Sorrento Therapeutics Oncolytic Virus Drug Treatment Product and Solutions
    Table 48. Sorrento Therapeutics Oncolytic Virus Drug Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Sorrento Therapeutics Recent Developments and Future Plans
    Table 50. Lokon Pharma Company Information, Head Office, and Major Competitors
    Table 51. Lokon Pharma Major Business
    Table 52. Lokon Pharma Oncolytic Virus Drug Treatment Product and Solutions
    Table 53. Lokon Pharma Oncolytic Virus Drug Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. Lokon Pharma Recent Developments and Future Plans
    Table 55. Genelux Corporation Company Information, Head Office, and Major Competitors
    Table 56. Genelux Corporation Major Business
    Table 57. Genelux Corporation Oncolytic Virus Drug Treatment Product and Solutions
    Table 58. Genelux Corporation Oncolytic Virus Drug Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 59. Genelux Corporation Recent Developments and Future Plans
    Table 60. Vyriad Company Information, Head Office, and Major Competitors
    Table 61. Vyriad Major Business
    Table 62. Vyriad Oncolytic Virus Drug Treatment Product and Solutions
    Table 63. Vyriad Oncolytic Virus Drug Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 64. Vyriad Recent Developments and Future Plans
    Table 65. TILT Biotherapeutics Company Information, Head Office, and Major Competitors
    Table 66. TILT Biotherapeutics Major Business
    Table 67. TILT Biotherapeutics Oncolytic Virus Drug Treatment Product and Solutions
    Table 68. TILT Biotherapeutics Oncolytic Virus Drug Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 69. TILT Biotherapeutics Recent Developments and Future Plans
    Table 70. Cold Genesys Company Information, Head Office, and Major Competitors
    Table 71. Cold Genesys Major Business
    Table 72. Cold Genesys Oncolytic Virus Drug Treatment Product and Solutions
    Table 73. Cold Genesys Oncolytic Virus Drug Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 74. Cold Genesys Recent Developments and Future Plans
    Table 75. Global Oncolytic Virus Drug Treatment Revenue (USD Million) by Players (2019-2024)
    Table 76. Global Oncolytic Virus Drug Treatment Revenue Share by Players (2019-2024)
    Table 77. Breakdown of Oncolytic Virus Drug Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 78. Market Position of Players in Oncolytic Virus Drug Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 79. Head Office of Key Oncolytic Virus Drug Treatment Players
    Table 80. Oncolytic Virus Drug Treatment Market: Company Product Type Footprint
    Table 81. Oncolytic Virus Drug Treatment Market: Company Product Application Footprint
    Table 82. Oncolytic Virus Drug Treatment New Market Entrants and Barriers to Market Entry
    Table 83. Oncolytic Virus Drug Treatment Mergers, Acquisition, Agreements, and Collaborations
    Table 84. Global Oncolytic Virus Drug Treatment Consumption Value (USD Million) by Type (2019-2024)
    Table 85. Global Oncolytic Virus Drug Treatment Consumption Value Share by Type (2019-2024)
    Table 86. Global Oncolytic Virus Drug Treatment Consumption Value Forecast by Type (2025-2030)
    Table 87. Global Oncolytic Virus Drug Treatment Consumption Value by Application (2019-2024)
    Table 88. Global Oncolytic Virus Drug Treatment Consumption Value Forecast by Application (2025-2030)
    Table 89. North America Oncolytic Virus Drug Treatment Consumption Value by Type (2019-2024) & (USD Million)
    Table 90. North America Oncolytic Virus Drug Treatment Consumption Value by Type (2025-2030) & (USD Million)
    Table 91. North America Oncolytic Virus Drug Treatment Consumption Value by Application (2019-2024) & (USD Million)
    Table 92. North America Oncolytic Virus Drug Treatment Consumption Value by Application (2025-2030) & (USD Million)
    Table 93. North America Oncolytic Virus Drug Treatment Consumption Value by Country (2019-2024) & (USD Million)
    Table 94. North America Oncolytic Virus Drug Treatment Consumption Value by Country (2025-2030) & (USD Million)
    Table 95. Europe Oncolytic Virus Drug Treatment Consumption Value by Type (2019-2024) & (USD Million)
    Table 96. Europe Oncolytic Virus Drug Treatment Consumption Value by Type (2025-2030) & (USD Million)
    Table 97. Europe Oncolytic Virus Drug Treatment Consumption Value by Application (2019-2024) & (USD Million)
    Table 98. Europe Oncolytic Virus Drug Treatment Consumption Value by Application (2025-2030) & (USD Million)
    Table 99. Europe Oncolytic Virus Drug Treatment Consumption Value by Country (2019-2024) & (USD Million)
    Table 100. Europe Oncolytic Virus Drug Treatment Consumption Value by Country (2025-2030) & (USD Million)
    Table 101. Asia-Pacific Oncolytic Virus Drug Treatment Consumption Value by Type (2019-2024) & (USD Million)
    Table 102. Asia-Pacific Oncolytic Virus Drug Treatment Consumption Value by Type (2025-2030) & (USD Million)
    Table 103. Asia-Pacific Oncolytic Virus Drug Treatment Consumption Value by Application (2019-2024) & (USD Million)
    Table 104. Asia-Pacific Oncolytic Virus Drug Treatment Consumption Value by Application (2025-2030) & (USD Million)
    Table 105. Asia-Pacific Oncolytic Virus Drug Treatment Consumption Value by Region (2019-2024) & (USD Million)
    Table 106. Asia-Pacific Oncolytic Virus Drug Treatment Consumption Value by Region (2025-2030) & (USD Million)
    Table 107. South America Oncolytic Virus Drug Treatment Consumption Value by Type (2019-2024) & (USD Million)
    Table 108. South America Oncolytic Virus Drug Treatment Consumption Value by Type (2025-2030) & (USD Million)
    Table 109. South America Oncolytic Virus Drug Treatment Consumption Value by Application (2019-2024) & (USD Million)
    Table 110. South America Oncolytic Virus Drug Treatment Consumption Value by Application (2025-2030) & (USD Million)
    Table 111. South America Oncolytic Virus Drug Treatment Consumption Value by Country (2019-2024) & (USD Million)
    Table 112. South America Oncolytic Virus Drug Treatment Consumption Value by Country (2025-2030) & (USD Million)
    Table 113. Middle East & Africa Oncolytic Virus Drug Treatment Consumption Value by Type (2019-2024) & (USD Million)
    Table 114. Middle East & Africa Oncolytic Virus Drug Treatment Consumption Value by Type (2025-2030) & (USD Million)
    Table 115. Middle East & Africa Oncolytic Virus Drug Treatment Consumption Value by Application (2019-2024) & (USD Million)
    Table 116. Middle East & Africa Oncolytic Virus Drug Treatment Consumption Value by Application (2025-2030) & (USD Million)
    Table 117. Middle East & Africa Oncolytic Virus Drug Treatment Consumption Value by Country (2019-2024) & (USD Million)
    Table 118. Middle East & Africa Oncolytic Virus Drug Treatment Consumption Value by Country (2025-2030) & (USD Million)
    Table 119. Oncolytic Virus Drug Treatment Raw Material
    Table 120. Key Suppliers of Oncolytic Virus Drug Treatment Raw Materials
List of Figures
    Figure 1. Oncolytic Virus Drug Treatment Picture
    Figure 2. Global Oncolytic Virus Drug Treatment Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Oncolytic Virus Drug Treatment Consumption Value Market Share by Type in 2023
    Figure 4. Phase 1
    Figure 5. Phase 2
    Figure 6. Others
    Figure 7. Global Oncolytic Virus Drug Treatment Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 8. Oncolytic Virus Drug Treatment Consumption Value Market Share by Application in 2023
    Figure 9. Melanoma Picture
    Figure 10. Prostate Cancer Picture
    Figure 11. Breast Cancer Picture
    Figure 12. Ovarian Cancer Picture
    Figure 13. Others Picture
    Figure 14. Global Oncolytic Virus Drug Treatment Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 15. Global Oncolytic Virus Drug Treatment Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 16. Global Market Oncolytic Virus Drug Treatment Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 17. Global Oncolytic Virus Drug Treatment Consumption Value Market Share by Region (2019-2030)
    Figure 18. Global Oncolytic Virus Drug Treatment Consumption Value Market Share by Region in 2023
    Figure 19. North America Oncolytic Virus Drug Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 20. Europe Oncolytic Virus Drug Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 21. Asia-Pacific Oncolytic Virus Drug Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 22. South America Oncolytic Virus Drug Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 23. Middle East and Africa Oncolytic Virus Drug Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 24. Global Oncolytic Virus Drug Treatment Revenue Share by Players in 2023
    Figure 25. Oncolytic Virus Drug Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 26. Global Top 3 Players Oncolytic Virus Drug Treatment Market Share in 2023
    Figure 27. Global Top 6 Players Oncolytic Virus Drug Treatment Market Share in 2023
    Figure 28. Global Oncolytic Virus Drug Treatment Consumption Value Share by Type (2019-2024)
    Figure 29. Global Oncolytic Virus Drug Treatment Market Share Forecast by Type (2025-2030)
    Figure 30. Global Oncolytic Virus Drug Treatment Consumption Value Share by Application (2019-2024)
    Figure 31. Global Oncolytic Virus Drug Treatment Market Share Forecast by Application (2025-2030)
    Figure 32. North America Oncolytic Virus Drug Treatment Consumption Value Market Share by Type (2019-2030)
    Figure 33. North America Oncolytic Virus Drug Treatment Consumption Value Market Share by Application (2019-2030)
    Figure 34. North America Oncolytic Virus Drug Treatment Consumption Value Market Share by Country (2019-2030)
    Figure 35. United States Oncolytic Virus Drug Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 36. Canada Oncolytic Virus Drug Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 37. Mexico Oncolytic Virus Drug Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 38. Europe Oncolytic Virus Drug Treatment Consumption Value Market Share by Type (2019-2030)
    Figure 39. Europe Oncolytic Virus Drug Treatment Consumption Value Market Share by Application (2019-2030)
    Figure 40. Europe Oncolytic Virus Drug Treatment Consumption Value Market Share by Country (2019-2030)
    Figure 41. Germany Oncolytic Virus Drug Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 42. France Oncolytic Virus Drug Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 43. United Kingdom Oncolytic Virus Drug Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 44. Russia Oncolytic Virus Drug Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 45. Italy Oncolytic Virus Drug Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 46. Asia-Pacific Oncolytic Virus Drug Treatment Consumption Value Market Share by Type (2019-2030)
    Figure 47. Asia-Pacific Oncolytic Virus Drug Treatment Consumption Value Market Share by Application (2019-2030)
    Figure 48. Asia-Pacific Oncolytic Virus Drug Treatment Consumption Value Market Share by Region (2019-2030)
    Figure 49. China Oncolytic Virus Drug Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 50. Japan Oncolytic Virus Drug Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 51. South Korea Oncolytic Virus Drug Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 52. India Oncolytic Virus Drug Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 53. Southeast Asia Oncolytic Virus Drug Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 54. Australia Oncolytic Virus Drug Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 55. South America Oncolytic Virus Drug Treatment Consumption Value Market Share by Type (2019-2030)
    Figure 56. South America Oncolytic Virus Drug Treatment Consumption Value Market Share by Application (2019-2030)
    Figure 57. South America Oncolytic Virus Drug Treatment Consumption Value Market Share by Country (2019-2030)
    Figure 58. Brazil Oncolytic Virus Drug Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 59. Argentina Oncolytic Virus Drug Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 60. Middle East and Africa Oncolytic Virus Drug Treatment Consumption Value Market Share by Type (2019-2030)
    Figure 61. Middle East and Africa Oncolytic Virus Drug Treatment Consumption Value Market Share by Application (2019-2030)
    Figure 62. Middle East and Africa Oncolytic Virus Drug Treatment Consumption Value Market Share by Country (2019-2030)
    Figure 63. Turkey Oncolytic Virus Drug Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 64. Saudi Arabia Oncolytic Virus Drug Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 65. UAE Oncolytic Virus Drug Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 66. Oncolytic Virus Drug Treatment Market Drivers
    Figure 67. Oncolytic Virus Drug Treatment Market Restraints
    Figure 68. Oncolytic Virus Drug Treatment Market Trends
    Figure 69. Porters Five Forces Analysis
    Figure 70. Manufacturing Cost Structure Analysis of Oncolytic Virus Drug Treatment in 2023
    Figure 71. Manufacturing Process Analysis of Oncolytic Virus Drug Treatment
    Figure 72. Oncolytic Virus Drug Treatment Industrial Chain
    Figure 73. Methodology
    Figure 74. Research Process and Data Source

Companies Mentioned

Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys